MRPL15 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.203200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.545200E-01
Normal-vs-Stage2
4.065600E-01
Normal-vs-Stage3
9.331000E-01
Normal-vs-Stage4
7.396400E-01
Stage1-vs-Stage2
9.749600E-01
Stage1-vs-Stage3
4.100400E-01
Stage1-vs-Stage4
6.304800E-01
Stage2-vs-Stage3
2.933600E-01
Stage2-vs-Stage4
5.517800E-01
Stage3-vs-Stage4
7.096000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.148400E-01
Normal-vs-AfricanAmerican
6.386800E-01
Normal-vs-Asian
5.574000E-01
Caucasian-vs-AfricanAmerican
5.297800E-01
Caucasian-vs-Asian
7.708400E-01
AfricanAmerican-vs-Asian
7.286400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.502200E-01
Normal-vs-Female
3.859800E-01
Male-vs-Female
9.376600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.182000E-01
Normal-vs-Age(41-60Yrs)
3.805800E-01
Normal-vs-Age(61-80Yrs)
4.642400E-01
Normal-vs-Age(81-100Yrs)
1.962040E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.530000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.246600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.524420E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.198400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.721200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.435800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.116200E-01
Normal-vs-Daily Drinker
4.401600E-01
Normal-vs-Weekly Drinker
4.042000E-01
Normal-vs-Occasional Drinker
3.608200E-01
Normal-vs-Social Drinker
4.274000E-01
Non Drinker-vs-Daily Drinker
2.784600E-01
Non Drinker-vs-Weekly Drinker
4.682000E-01
Non Drinker-vs-Occasional Drinker
5.438800E-01
Non Drinker-vs-Social Drinker
4.595200E-01
Daily Drinker-vs-Weekly Drinker
7.122200E-01
Daily Drinker-vs-Occasional Drinker
5.302400E-01
Daily Drinker-vs-Social Drinker
7.178600E-01
Weekly Drinker-vs-Occasional Drinker
8.381600E-01
Weekly Drinker-vs-Social Drinker
9.894400E-01
Occasional Drinker-vs-Social Drinker
8.296200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.763400E-01
Normal-vs-Grade 2
7.962400E-01
Normal-vs-Grade 3
3.943800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.404400E-02
Grade 1-vs-Grade 3
2.174000E-02
Grade 1-vs-Grade 4
8.763400E-01
Grade 2-vs-Grade 3
2.199200E-01
Grade 2-vs-Grade 4
7.962400E-01
Grade 3-vs-Grade 4
3.943800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.196600E-01
Normal-vs-NonDiabetic
4.355600E-01
Diabetic-vs-NonDiabetic
3.984400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.588000E-01
Normal-vs-NoPancreatitis
4.279000E-01
Pancreatitis-vs-NoPancreatitis
5.676000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.546600E-01
Normal-vs-N1
3.907400E-01
N0-vs-N1
8.907000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.472840E-01
Normal-vs-TP53-NonMutant
7.454200E-01
TP53-Mutant-vs-TP53-NonMutant
1.68520999999089E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
